Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Dingdang Health Technology Group Days Payable?
Dingdang Health Technology GroupHKSE:09886 -1.22%68 Days Payable is 69.43 as of Jun. 2026, which is 65% above its 10-year median of 42.08. GuruFocus rates HKSE:09886 with a GF Score™ of 68/100 and a GF Value™ of HK$1.13 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 612 Healthcare Providers & Services companies, Dingdang Health Technology Group ranks worse than 52.94% on this metric.
The historical rank and industry rank for Dingdang Health Technology Group's Days Payable or its related term are showing as below:
HKSE:09886'
s Days Payable Range Over the Past 10 Years
Min: 34.18 Med: 42.08 Max: 52.63
Current: 52.63
During the past 8 years, Dingdang Health Technology Group's highest Days Payable was 52.63. The lowest was 34.18. And the median was 42.08.
HKSE:09886's Days Payable is ranked worse than 52.94% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: 56.91
vs HKSE:09886: 52.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dingdang Health Technology Group Days Payable Chart
HKSE:09886 vs VEEV, BTSG, HQY: Days Payable Comparison
For the Health Information Services subindustry, Dingdang Health Technology Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dingdang Health Technology Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Dingdang Health Technology Group's Days Payable falls into.
Dingdang Health Technology Group Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dingdang Health Technology Group (HKSE:09886) has a Days Payable of 69.43 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dingdang Health Technology Group and its competitors. This is 65% above median its historical median of 42.08. Over the past decade, Dingdang Health Technology Group's Days Payable has ranged from 34.18 to 52.63. According to the industry distribution chart, Dingdang Health Technology Group ranks #324 out of 612 companies in the Healthcare Providers & Services industry, placing it in the top 52.9%.
Is Dingdang Health Technology Group's Days Payable too high?
Dingdang Health Technology Group's current Days Payable of 69.43 is 65% above median its 10-year median of 42.08. Over the past 10 years, this metric has ranged from a low of 34.18 to a high of 52.63. The Healthcare Providers & Services industry median Days Payable is 56.91. Dingdang Health Technology Group's value of 69.43 is 22% above this industry median. Based on the distribution chart, Dingdang Health Technology Group ranks #324 out of 612 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Dingdang Health Technology Group has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dingdang Health Technology Group's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Dingdang Health Technology Group ranks #324 out of 612 companies for Days Payable. This places Dingdang Health Technology Group in the lower half of its industry. The industry median Days Payable is 56.91. Dingdang Health Technology Group's value of 69.43 is 22% above this benchmark. Historically, Dingdang Health Technology Group's own Days Payable has ranged from 34.18 to 52.63 over the past decade. While the company's 10-year median is 42.08 vs. the industry median of 56.91, Dingdang Health Technology Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.91, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dingdang Health Technology Group's current Days Payable of 69.43 is 22% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dingdang Health Technology Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dingdang Health Technology Group's current Days Payable is 69.43, which is 65% above median its own 10-year median of 42.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dingdang Health Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dingdang Health Technology Group (HKSE:09886) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.13, compared to a current price of HK$0.81 — trading 28.3% below its estimated fair value. The current Days Payable is 69.43, which is 65% above median its 10-year median of 42.08 and 22% above the Healthcare Providers & Services industry median of 56.91. Dingdang Health Technology Group's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Dingdang Health Technology Group (HKSE:09886), the current Days Payable is 69.43 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dingdang Health Technology Group (HKSE:09886) Overvalued in 2026?
Based on GuruFocus' analysis, Dingdang Health Technology Group stock appears to be undervalued.
The current stock price of HK$0.81 is trading 28.3% below its estimated GF Value™ of HK$1.13.
GuruFocus considers Dingdang Health Technology Group to be Possible Value Trap.
Key valuation signals for HKSE:09886:
Days Payable: 69.43 (65% above median its 10-year median of 42.08)
GF Value™: HK$1.13 vs. price of HK$0.81 (28.3% below fair value)
Industry Position: 22% above the Healthcare Providers & Services median (#324 of 612)
No single metric tells the full story. See the HKSE:09886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions. All of the company's revenue is generated from the PRC.
68GF Score
Get the complete analysis for HKSE:09886
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09886 has been successfully added to your 
